LNTH
Lantheus Holdings, Inc.Healthcare · $6.5B market cap
Verdict
Share price
$99.96
close of Oct 3, 2026
Fair value
$49.55
Sticker Price
Payback Price
$19.82
buy price
LNTH is Overpriced: at $99.96 it trades 102% above its fair value of $49.55. Its buy price (Payback Price) is $19.82, 80% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow LNTH
Get notified when it reaches its buy price of $19.82. Free.
Create a free accountSuperinvestors
1 of the investors we track holds LNTH. In Q2 2026, 1 opened a position. Who we track
Moves in Q2 2026
New position: First Eagle Investment Management
Insider activity
Since Aug 17, 2026: no open-market purchases and 3 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Lantheus Holdings, Inc.
Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio…
Drug Manufacturers - Specialty & Generic
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works